BCVA and CST Improvement over 12 weeks with OCS-01 Eye Drops in DME From DIAMOND-Stage 1 trial (ARVO 2025) - Mar 26, 2025 - Abstract #4011; Pres time: May 7, 2025; 10:15 AM - 10:30 AM; Location: 255ABC; "Layman Abstract (optional): Provide a 50-200 word description of your work that non-scientists can understand. Describe the big picture and the implications of your findings, not the study itself and the associated details."
Diabetic Macular Edema • Ophthalmology
|
|
Carl Danzig1; Arshad M. Khanani2; David S. Boyer3; Quan Dong Nguyen4; Sabri Markabi5
|